A First-in-human Trial of Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
A First-in-human Trial of Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
批准号:
446711
负责人:
Shapiro James
金额:
$0.73万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-12-01 至 2021-12-01
中文摘要
糖尿病是由于缺乏胰岛素引起的,胰岛素是一种由胰腺中的胰岛β细胞产生的调节血糖的激素。在1型糖尿病(T1 D,~10%)中,β细胞被自身免疫系统破坏。在2型糖尿病(T2 D,~90%)中,身体B
英文摘要
Diabetes is caused by the lack of insulin, a hormone produced by the islet ß-cells in the pancreas that regulates blood sugar. In Type 1 Diabetes (T1D, ~10%), the ß-cells are destroyed by one's own immune system. In Type 2 Diabetes (T2D, ~90%), the body b
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
-
批准号:454362
-
项目类别:Operating Grants
-
资助金额:$72.85万
-
财政年份:2021
-
负责人:Shapiro James
-
依托单位:
Canada Research Chairs - Tier 1
-
批准号:441789
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2020
-
负责人:Shapiro James
-
依托单位:
Preclinical Development of Novel Biomaterials for the Creation of a Deviceless Pre-Vascularized Site for Islet and Cellular Transplantation
-
批准号:335133
-
项目类别:Operating Grants
-
资助金额:$11.45万
-
财政年份:2015
-
负责人:Shapiro James
-
依托单位:
CANADA RESEARCH CHAIRHOLDER - Tier 1 / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA - Niveau 1
-
批准号:302789
-
项目类别:
-
资助金额:$101.99万
-
财政年份:2013
-
负责人:Shapiro James
-
依托单位:
海外基金